Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

Atrial Fibrillation

  • Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation
    You have accessRestricted Access
    Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation
    Thomas A. Mavrakanas, Katherine Garlo and David M. Charytan
    CJASN August 2020, 15 (8) 1146-1154; DOI: https://doi.org/10.2215/CJN.11650919
    Add to Selected Citations
  • Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis
    You have accessRestricted Access
    Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis
    Tara I-Hsin Chang, Sai Liu, Medha Airy, Jingbo Niu, Mintu P. Turakhia, Jennifer E. Flythe, Maria E. Montez-Rath and Wolfgang C. Winkelmayer
    CJASN July 2019, 14 (7) 1029-1038; DOI: https://doi.org/10.2215/CJN.13511118
    Add to Selected Citations
  • Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes
    You have accessRestricted Access
    Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes
    Nazem Akoum, Leila R. Zelnick, Ian H. de Boer, Irl B. Hirsch, Dace Trence, Connor Henry, Nicole Robinson and Nisha Bansal
    CJASN April 2019, 14 (4) 549-556; DOI: https://doi.org/10.2215/CJN.09420818
    Add to Selected Citations
  • Open Access
    Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease
    Nishank Jain and Robert F. Reilly
    CJASN February 2019, 14 (2) 278-287; DOI: https://doi.org/10.2215/CJN.02170218
    Add to Selected Citations
  • You have accessRestricted Access
    Commentary on “Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in CKD”
    Bryan R. Kestenbaum and Stephen L. Seliger
    CJASN January 2019, 14 (1) 137-138; DOI: https://doi.org/10.2215/CJN.13431118
    Add to Selected Citations
  • Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease
    You have accessRestricted Access
    Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease
    Juan Jesus Carrero, Marco Trevisan, Manish M. Sood, Peter Bárány, Hong Xu, Marie Evans, Leif Friberg and Karolina Szummer
    CJASN September 2018, 13 (9) 1314-1320; DOI: https://doi.org/10.2215/CJN.04060318
    Add to Selected Citations
  • Open Access
    The ABCs in the Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease
    Christoph Wanner
    CJASN September 2018, 13 (9) 1421-1422; DOI: https://doi.org/10.2215/CJN.09090718
    Add to Selected Citations
  • Open Access
    Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease
    Wolfgang C. Winkelmayer
    CJASN September 2018, 13 (9) 1423-1425; DOI: https://doi.org/10.2215/CJN.06270518
    Add to Selected Citations
  • Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
    You have accessRestricted Access
    Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
    Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams
    CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217
    Add to Selected Citations
  • You have accessRestricted Access
    Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD
    Rupal Mehta and Tamara Isakova
    CJASN December 2017, 12 (12) 1911-1913; DOI: https://doi.org/10.2215/CJN.11011017
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire